ABSTRACT
@#The main toxic component of tetramine is tetramethylenedisulfotetramine (TETS). It is a sulfonamide derivative without special antidote, tasteless and tasteless, with high toxicity and high mortality.[1]It was first discovered by a German scientist Hagen in 1949. Although its use has been banned worldwide due to its high toxicity and mortality rate, it is still available in certain countries and has led to cases of intentional and unintentional poisoning. Tetramine blocks γ-neurons, leading to dizziness, fatigue, nausea, vomiting, convulsions, and other symptoms.[2-4]Due to the lack of recognized effective antidotes, many poisoned people suffocate and die as a result of continuous spasms of the respiratory muscles.[5-7] Tetramine poisoning sometimes occurs, but it is rare for vegetables grown in tetramine-contaminated soil to cause group poisoning after being eaten.
ABSTRACT
OBJECTIVE:To provide reference for upgrading emergency management of pharmaceutical affairs and enhancing the safety and effectiveness of clinical medication.METHODS:The guiding effect of evidence-based parmacy(EBP)on emergency management of pharmaceutical affair security especially on the choice of drugs in clinical medication were discussed by elaborating the example of seeking sovereign remedy for tetramine acute poisoning.RESULTS & CONCLUSIONS:Emplying the principle of EBP to guide clinical medication can help to choose more effective and safe drugs and to find the best emergency treatment scheme.